Literature DB >> 25755527

Hepatitis C virus heterogeneity: lipoprotein and immunoglobulin binding and clinical status.

Nikki Rae Adler1, Marian Biddle1, Lauren Beswick2, Christopher Hair2, Benjamin Allen2, Stephen Graves3, Aminul Islam3, Jonathan P Watson1.   

Abstract

Entities:  

Year:  2013        PMID： 25755527      PMCID： PMC3940519          DOI： 10.1016/j.jceh.2013.08.010

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN： 0973-6883


× No keyword cloud information.
  9 in total

1.  Hepatitis C virus and other flaviviridae viruses enter cells via low density lipoprotein receptor.

Authors:  V Agnello; G Abel; M Elfahal; G B Knight; Q X Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

2.  Density heterogeneities of hepatitis C virus in human sera due to the binding of beta-lipoproteins and immunoglobulins.

Authors:  R Thomssen; S Bonk; A Thiele
Journal:  Med Microbiol Immunol       Date:  1993-12       Impact factor: 3.402

Review 3.  Global epidemiology of hepatitis C virus infection.

Authors:  Colin W Shepard; Lyn Finelli; Miriam J Alter
Journal:  Lancet Infect Dis       Date:  2005-09       Impact factor: 25.071

4.  The low-density lipoprotein receptor plays a role in the infection of primary human hepatocytes by hepatitis C virus.

Authors:  Sonia Molina; Valérie Castet; Chantal Fournier-Wirth; Lydiane Pichard-Garcia; Rachel Avner; Dror Harats; Joseph Roitelman; Ronald Barbaras; Pierre Graber; Paola Ghersa; Moshe Smolarsky; Ada Funaro; Fabio Malavasi; Dominique Larrey; Joliette Coste; Jean-Michel Fabre; Antonio Sa-Cunha; Patrick Maurel
Journal:  J Hepatol       Date:  2006-11-13       Impact factor: 25.083

5.  Hepatitis C virus density heterogeneity and viral titre in acute and chronic infection: a comparison of immunodeficient and immunocompetent patients.

Authors:  J P Watson; D J Bevitt; G P Spickett; G L Toms; M F Bassendine
Journal:  J Hepatol       Date:  1996-11       Impact factor: 25.083

6.  Hepatitis C virus particles of different density in the blood of chronically infected immunocompetent and immunodeficient patients: Implications for virus clearance by antibody.

Authors:  W Pumeechockchai; D Bevitt; K Agarwal; T Petropoulou; B C A Langer; B Belohradsky; M F Bassendine; G L Toms
Journal:  J Med Virol       Date:  2002-11       Impact factor: 2.327

7.  Serum and liver HCV RNA levels in patients with chronic hepatitis C: correlation with clinical and histological features.

Authors:  L De Moliner; P Pontisso; G L De Salvo; L Cavalletto; L Chemello; A Alberti
Journal:  Gut       Date:  1998-06       Impact factor: 23.059

Review 8.  HCV-related burden of disease in Europe: a systematic assessment of incidence, prevalence, morbidity, and mortality.

Authors:  Nikolai Mühlberger; Ruth Schwarzer; Beate Lettmeier; Gaby Sroczynski; Stefan Zeuzem; Uwe Siebert
Journal:  BMC Public Health       Date:  2009-01-22       Impact factor: 3.295

Review 9.  Potential cellular receptors involved in hepatitis C virus entry into cells.

Authors:  Daniel Favre; Beat Muellhaupt
Journal:  Lipids Health Dis       Date:  2005-04-19       Impact factor: 3.876
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.